Glembatumumab vedotin (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Glembatumumab vedotin" in Italian language version.

refsWebsite

Global rank Italian rank

799^th place

22^nd place

2^nd place

7^th place

4^th place

9^th place

2clinicaltrials.gov

5,225^th place

5,296^th place

1web.archive.org

1^st place

1^st place

clinicaltrials.gov

NCT00412828, su clinicaltrials.gov, 9 settembre 2009. URL consultato il 30 dicembre 2009.
«A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma»
NCT00704158, su clinicaltrials.gov, 9 settembre 2009. URL consultato il 30 dicembre 2009.
«Study of CR011-vcMMAE to Treat Locally Advanced or Metastatic Breast Cancer»

doi.org

dx.doi.org

X. Qian, E. Mills; M. Torgov; WJ. LaRochelle; M. Jeffers, Pharmacologically enhanced expression of GPNMB increases the sensitivity of melanoma cells to the CR011-vcMMAE antibody-drug conjugate., in Mol Oncol, vol. 2, n. 1, giugno 2008, pp. 81-93, DOI:10.1016/j.molonc.2008.02.002, PMID 19383330.
AA. Rose, AA. Grosset; Z. Dong; C. Russo; PA. Macdonald; NR. Bertos; Y. St-Pierre; R. Simantov; M. Hallett; M. Park; L. Gaboury, Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer., in Clin Cancer Res, vol. 16, n. 7, aprile 2010, pp. 2147-56, DOI:10.1158/1078-0432.CCR-09-1611, PMID 20215530.

nih.gov

ncbi.nlm.nih.gov

X. Qian, E. Mills; M. Torgov; WJ. LaRochelle; M. Jeffers, Pharmacologically enhanced expression of GPNMB increases the sensitivity of melanoma cells to the CR011-vcMMAE antibody-drug conjugate., in Mol Oncol, vol. 2, n. 1, giugno 2008, pp. 81-93, DOI:10.1016/j.molonc.2008.02.002, PMID 19383330.
AA. Rose, AA. Grosset; Z. Dong; C. Russo; PA. Macdonald; NR. Bertos; Y. St-Pierre; R. Simantov; M. Hallett; M. Park; L. Gaboury, Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer., in Clin Cancer Res, vol. 16, n. 7, aprile 2010, pp. 2147-56, DOI:10.1158/1078-0432.CCR-09-1611, PMID 20215530.

oadoi.org

X. Qian, E. Mills; M. Torgov; WJ. LaRochelle; M. Jeffers, Pharmacologically enhanced expression of GPNMB increases the sensitivity of melanoma cells to the CR011-vcMMAE antibody-drug conjugate., in Mol Oncol, vol. 2, n. 1, giugno 2008, pp. 81-93, DOI:10.1016/j.molonc.2008.02.002, PMID 19383330.
AA. Rose, AA. Grosset; Z. Dong; C. Russo; PA. Macdonald; NR. Bertos; Y. St-Pierre; R. Simantov; M. Hallett; M. Park; L. Gaboury, Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer., in Clin Cancer Res, vol. 16, n. 7, aprile 2010, pp. 2147-56, DOI:10.1158/1078-0432.CCR-09-1611, PMID 20215530.

web.archive.org

(EN) CuraGen Announces Expansion Of CR011-vcMMAE Phase II Trial In Advanced Breast Cancer, su medicalnewstoday.com (archiviato dall'url originale il 20 giugno 2009).